Ekso Bionics Holdings Inc reports results for the quarter ended in September - Earnings Summary

Chronoscale

26/10/2023 22:41

* Ekso Bionics Holdings Inc  EKSO.OQ  reported a quarterly
adjusted loss of 24 cents​​ per share for the quarter ended in
September. The lone analyst forecast for the quarter was for a
loss of 31 cents per share.
    * Revenue rose 38.4% to $4.61 million from a year ago;
analysts
expected $4.50 million. 
    * Ekso Bionics Holdings Inc's reported EPS for the quarter
was a
loss of 24 cents​.
    * The mean earnings estimate of analysts had fallen by
about 6.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Ekso Bionics Holdings Inc shares had risen by 9.1% this
quarter and lost 32.8% so far this year.
    * The company reported a quarterly loss of $3.37 million.
    * Wall Street's median 12-month price target for Ekso
Bionics
Holdings Inc is $9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
October 26 at 09:40 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -0.31          -0.24          Beat
 Jun. 30 2023      -0.28          -0.31          Missed
 Mar. 31 2023      -0.31          -0.33          Missed